LATEST ALERTS
This report examines the main pathways for tobacco products to enter the market in the US, covering PMTAs, MRTPs and SEs
The US FDA’s granting of modified risk status to PMI’s IQOS system suggests possible future competition in the tobacco alternatives market, experts have told TobaccoIntelligence
The US Food and Drug Administration (FDA) has granted Philip Morris International (PMI) modified risk tobacco product (MRTP) status for Iqos and its associated HeatSticks
Lawmakers in the US state of North Carolina are considering amending the rules on tax breaks for approved tobacco alternatives
Republican lawmakers in the US state of Georgia are proposing that modified risk tobacco products could be taxed at a half portion of the rate traditional tobacco is charged
What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
The US Food and Drug Administration (FDA) has granted its first modified risk order for eight snus smokeless tobacco products to be sold with certain modified risk claims by Swedish Match USA
The US FDA has given its approval for Philip Morris International (PMI)’s IQOS in the US, along with its associated consumables ― the first heated-tobacco products to be so approved
Heated tobacco is grabbing headlines, but what else will it seize? We examine a number of market and regulatory scenarios with greatly differing outcomes for both heat-not-burn products and e-cigarettes
BAT has chosen to seek market authorisation in the US for its heat-not-burn product Glo on the basis of its “substantial equivalence” to a previous product, Eclipse – but what are the pitfalls and the advantages in this approach? …
The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
The US FDA has missed its own 180-day deadline for replying to the premarket tobacco application (PMTA) by Philip Morris International for its IQOS heated tobacco products
The American Vaping Association has written to FDA commissioner Scott Gottlieb urging him to approve PMI’s heated tobacco product iQOS for sale in the US
As PMI’s iQOS comes under consideration by the US FDA, we examine the hurdles it – and other – heated tobacco and e-cigarette products will have to clear to obtain authorisation for commercialisation and reduced-risk claims.
PMI has responded forcefully after a Swiss research team claimed its iQOS heat-not-burn system released “the same harmful constituents of conventional cigarette smoke”
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
